Marginal Zone Lymphoma
Showing NaN - NaN of 10
Non-hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Boston (CD79b-19 CAR T cells,
Not yet recruiting
- Non-hodgkin Lymphoma
- +9 more
- CD79b-19 CAR T cells
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital
Sep 6, 2023
Follicular Lymphoma, Marginal Zone Lymphoma, Indolent Non-hodgkin Lymphoma Trial in Boston (Obinutuzumab, Glofitamab)
Not yet recruiting
- Follicular Lymphoma
- +2 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Mar 13, 2023
Follicular Lymphoma, Marginal Zone Lymphoma Trial in Italy, Spain, United States (EO2463, lenalidomide, rituximab)
Recruiting
- Follicular Lymphoma
- Marginal Zone Lymphoma
- EO2463
- +2 more
-
Boston, Massachusetts
- +9 more
Jul 26, 2022
Collecting and Storing Tissue Samples From Rare or Cutaneous
Active, not recruiting
- Adult Immunoblastic Lymphoma
- +12 more
- Cytology Specimen Collection Procedure
-
Birmingham, Alabama
- +129 more
Mar 23, 2022
Chronic Lymphocytic Leukemia, DLBCL, Follicular Lymphoma Trial in Duarte, Boston, Portland (Copanlisib, Nivolumab)
Recruiting
- Chronic Lymphocytic Leukemia
- +6 more
- Copanlisib
- Nivolumab
-
Duarte, California
- +2 more
Mar 9, 2022
Follicular Lymphoma (FL), Non Hodgkin Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (Zandelisib (ME-401))
Recruiting
- Follicular Lymphoma (FL)
- +2 more
- Zandelisib (ME-401)
-
Tucson, Arizona
- +115 more
Mar 8, 2022
Follicular Lymphoma, Marginal Zone Lymphoma, Small Lymphocytic Lymphoma Trial in Boston (ofatumumab)
Completed
- Follicular Lymphoma
- +2 more
-
Boston, Massachusetts
- +2 more
Sep 18, 2017